arjunolic acid has been researched along with Kidney Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sherif, IO | 1 |
Pal, PB; Pal, S; Sarkar, A; Sil, PC | 1 |
Al-Gayyar, MM; Eladl, MA; Elsherbiny, NM | 1 |
3 other study(ies) available for arjunolic acid and Kidney Diseases
Article | Year |
---|---|
Amelioration of cisplatin-induced nephrotoxicity in rats by triterpenoid saponin of Terminalia arjuna.
Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Adhesion Molecules; Cisplatin; Drug Evaluation, Preclinical; Kidney; Kidney Diseases; Kidney Function Tests; Male; NF-kappa B; Oxidative Stress; Phytotherapy; Plant Extracts; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Terminalia; Transforming Growth Factor beta; Triterpenes | 2015 |
Protective effect of arjunolic acid against atorvastatin induced hepatic and renal pathophysiology via MAPK, mitochondria and ER dependent pathways.
Topics: Animals; Apoptosis; Atorvastatin; Chemical and Drug Induced Liver Injury; Endoplasmic Reticulum; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Diseases; Liver; Male; MAP Kinase Signaling System; Mice; Mitochondria, Liver; Oxidative Stress; Triterpenes | 2015 |
Renal protective effects of arjunolic acid in a cisplatin-induced nephrotoxicity model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cisplatin; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression; Interleukin-1beta; Kidney; Kidney Diseases; Kidney Function Tests; Male; NF-kappa B; Phytotherapy; Protective Agents; Protein Serine-Threonine Kinases; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; Terminalia; Transforming Growth Factor beta1; Triterpenes; Tumor Necrosis Factor-alpha | 2016 |